Impact of IPDE-SQ personality disorders on the healthcare and societal costs of fibromyalgia patients: a cross-sectional study

Laura Gumà-Uriel, M Teresa Peñarrubia-María, Marta Cerdà-Lafont, Oriol Cunillera-Puertolas, Jesús Almeda-Ortega, Rita Fernández-Vergel, Javier García-Campayo, Juan V Luciano, Laura Gumà-Uriel, M Teresa Peñarrubia-María, Marta Cerdà-Lafont, Oriol Cunillera-Puertolas, Jesús Almeda-Ortega, Rita Fernández-Vergel, Javier García-Campayo, Juan V Luciano

Abstract

Background: Data is lacking on comorbid personality disorders (PD) and fibromyalgia syndrome (FMS) in terms of prevalence, and associated healthcare and societal costs. The main aim of this study was to assess the prevalence of PD in FMS patients and to analyse whether the presence of comorbid PD is related to worse functional impairment and greater healthcare (medical visits, drug consumption, and medical tests) and societal costs.

Methods: A cross-sectional study was performed using the baseline data of 216 FMS patients participating in a randomized, controlled trial carried out in three primary health care centres situated in the region of Barcelona, Spain. Measurement instruments included the International Personality Disorder Examination - Screening Questionnaire (IPDE-SQ), the Fibromyalgia Impact Questionnaire (FIQ), the Client Service Receipt Inventory (CSRI), and a socio-demographic questionnaire.

Results: Most patients (65 %) had a potential PD according to the IPDE-SQ. The most prevalent PD were the avoidant (41.4 %), obsessive-compulsive (33.1 %), and borderline (27 %). We found statistically significant differences in functional impairment (FIQ scores) between FMS patients with potential PD vs non-PD (59.2 vs 51.1; p < 0.001). Multivariate regression analyses revealed that higher FIQ total scores and the presence of potential PD were related to more healthcare costs (primary and specialised care visits).

Conclusions: As expected, PD are frequent comorbid conditions in patients with FMS. Our results suggest that the screening of comorbid PD in patients with FMS might be recommendable in order to detect potential frequent attenders to primary and specialised care.

Keywords: Direct costs; Fibromyalgia syndrome; Indirect costs; Personality disorders.

Figures

Fig. 1
Fig. 1
Flow diagram of the participants in the FibroQoL study who completed the IPDE-SQ

References

    1. World Health Organization. International Statistical Classification of Diseases and Related Problems. ICD-10. Geneva: WHO; 1992.
    1. Collado A, Alijotas J, Benito P, Alegre C, Romera M, Sañudo I, et al. Consensus report on the diagnosis and treatment of fibromyalgia in Catalonia. Med Clin Barc. 2002;118:745–9.
    1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. The american college of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum. 1990;33:160–72. doi: 10.1002/art.1780330203.
    1. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB. The american college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62:600–10. doi: 10.1002/acr.20140.
    1. Häuser W, Ablin J, Fitzcharles MA, Littlejohn G, Luciano JV, Usui C, Walitt B. Fibromyalgia. Fibromyalgia. Nat Rev Dis Primers. 2015;1:15022.
    1. Carmona L, Ballina J, Gabriel R, Laffon A, EPISER Study Group The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis. 2001;60:1040–5. doi: 10.1136/ard.60.11.1040.
    1. Gamero Ruiz F, Gabriel Sánchez R, Carbonell Abello J, Tornero Molina J, Sánchez-Magro I. Pain in spanish rheumatology outpatient offices: EPIDOR epidemiological study. Rev Clin Esp. 2005;205:157–63. doi: 10.1157/13074161.
    1. Sicras-Mainar A, Rejas J, Navarro R, Blanca M, Morcillo A, Larios R, Velasco S, Villarroya C. Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study. Arthritis Res Ther. 2009;11:R54. doi: 10.1186/ar2673.
    1. Berger A, Dukes E, Martin S, Edelsberg J, Oster G. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract. 2007;61:1498–508. doi: 10.1111/j.1742-1241.2007.01480.x.
    1. Bernatsky S, Dobkin PL, De Civita M, Penrod JR. Co-morbidity and physician use in fibromyalgia. Swiss Med Wkly. 2005;135:76–81.
    1. Villarraga AR, Castellanos ALZ, Anaya JM, Tamayo RP. Predictores de calidad de vida en pacientes con fibromialgia [Predictors of quality of life in patients with fibromyalgia] Rev Colomb Reumatol. 2005;12:295–300.
    1. Torres Villar OC, Martínez Barreira A, Soriano Villanueva DL, Fernández-Vergel R, Luciano JV, Peñarrubia-María MT. Relación entre comorbilidad y estado funcional en pacientes de atención primaria con fibromialgia (estudio FIBROQOL) [Relationship between comorbodity and functional status in primary care patients with fibromyalgia] Butlletí. 2013;31:3.
    1. Martinez JE, Ferraz MB, Fontana AM, Atra E. Psychological aspects of Brazilian women with fibromyalgia. J Psychosom Res. 1995;39:167–74. doi: 10.1016/0022-3999(94)00093-K.
    1. Rose S, Cottencin O, Chouraki V, Wattier JM, Houvenagel E, Vallet B, Vallet B, Goudemand M. Study on personality and psychiatric disorder in fibromyalgia. Presse Med. 2009;38:695–700.
    1. Uguz F, Ciçek E, Salli A, Karahan AY, Albayrak I, Kaya N, et al. Axis I and axis II psychiatric disorders in patients with fibromyalgia. Gen Hosp Psychiatry. 2010;32:105–7.
    1. Samuels J. Personality disorders: epidemiology and public health issues. Int Rev Psychiatry. 2011;23:223–33. doi: 10.3109/09540261.2011.588200.
    1. Thieme K, Turk DC, Flor H. Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med. 2004;66:837–44. doi: 10.1097/01.psy.0000146329.63158.40.
    1. American Psychiatric Association . DSM-IV-R. Diagnostic and Statistical Manual of Mental Disorders. fourth. Washington, DC: APA; 1994.
    1. Blasco Claros L, Mallo Caño M, Mencía Presa A, Franch Barceló J, Casaus Satamán P, Peña Roca J, et al. Clinical profiles in fibromyalgia patients of the community mental health center: a predictive index of psychopathological severity. Actas Esp Psiquiatr. 2006;34:112–22.
    1. Luciano JV, Martínez N, Peñarrubia-María MT, Fernández-Vergel R, García-Campayo J, Verduras C, et al. Effectiveness of a psychoeducational treatment program implemented in general practice for fibromyalgia patients: a randomized controlled trial. Clin J Pain. 2011;27:383–91.
    1. Luciano JV, Sabes-Figuera R, Cardeñosa ET Peñarrubia-María M, Fernández-Vergel R, García-Campayo J, Knapp M, et al. Cost-utility of a psychoeducational intervention in fibromyalgia patients compared with usual care: an economic evaluation alongside a 12-month randomized controlled trial. Clin J Pain. 2013;29:702–11.
    1. Fernández R, Peñarubia MT, Luciano JV, Blanco ME, Jiménez M, Montesano A, et al. Effectiveness of a psycho-educational program for improving quality of life of fibromyalgia patients. BMC Musculoskelet Disord. 2008;9:2.
    1. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol. 1991;18:728–33.
    1. Rivera J, González T. The fibromyalgia impact questionnaire: a validated spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol. 2004;22:554–60.
    1. Beecham J, Knapp M. Meas. Ment. Health Needs. London: Gaskell; 1992. Costing psychiatric interventions; pp. 163–183.
    1. Vázquez-Barquero JL, Gaite L, Cuesta MJ, Garcia-Usieto E, Knapp M, Beecham J. Spanish version of the CSRI: a mental health cost evaluation interview. Arch Neurobiol. 1997;60:171–84.
    1. Loranger AW. Personality Disorder Examination (IPDE) Manual. DV Communication: Yonkers; 1995.
    1. López-Ibor JJ, Pérez-Urdániz A, Rubio V. Examen internacional para los Trastornos de la Personalidad. Módulo DSM-IV [The International Personality Disorders Examination. DSM-IV Module. Spanish version]. Organización Mundial de la Salud. Madrid: Meditor; 1996.
    1. Lenzenweger MF, Loranger AW, Korfine L, Neff C. Detecting personality disorders in a nonclinical population. Application of a 2-stage procedure for case identification. Arch Gen Psychiatry. 1997;54:345–51. doi: 10.1001/archpsyc.1997.01830160073010.
    1. Egan S, Nathan P, Lumley M. Diagnostic concordance of ICD-10 personality and comorbid disorders: a comparison of standard clinical assessment and structured interviews in a clinical setting. Aust N Z J Psychiatry. 2003;37:484–91. doi: 10.1046/j.1440-1614.2003.01226.x.
    1. Slade T, Peters L, Schneiden V, Andrews G. The International Personality Disorder Examination Questionnaire (IPDEQ): preliminary data on its utility as a screener for anxious personality disorder. Int J Methods Psychiatr Res. 1998;7:84–8. doi: 10.1002/mpr.37.
    1. Lewin TJ, Slade T, Andrews G, Carr VJ, Hornabrook CW. Assessing personality disorders in a national mental health survey. Soc Psychiatry Psychiatr Epidemiol. 2005;40:87–98. doi: 10.1007/s00127-005-0878-1.
    1. del Río EF, Vispo CM, Iglesias EB. Concordance between the IPDE screening questionnaire and the diagnosis of personality disorders in smokers. Behav Psychol. 2001;19:303–315.
    1. Blasco-Fontecilla H, Baca-Garcia E, Dervic K, Perez-Rodriguez MM, Saiz-Gonzalez MD, Saiz-Ruiz J, et al. Severity of personality disorders and suicide attempt. Acta Psychiatr Scand. 2009;119:149–55.
    1. Magallón-Neri EM, Forns M, Canalda G, De La Fuente JE, García R, González E, et al. Usefulness of the international personality disorder examination screening questionnaire for borderline and impulsive personality pathology in adolescents. Compr Psychiatry. 2013;54:301–8.
    1. Cong R. Marginal effects of the tobit model. Stata Tech. Bull. 2001;10:56.
    1. Bennett RM, Bushmakin AG, Cappelleri JC, Zlateva G, Sadosky AB. Minimal clinically important difference in the fibromyalgia impact questionnaire. J Rheumatol. 2009;36:1304–11. doi: 10.3899/jrheum.081090.
    1. Cerón Muñoz AM, Centelles Mañosa F, Abellana Senglà M, Garcia CS. Fibromyalgia and personality disorders. SEMERGEN. Med Fam. 2010;36:501–6.
    1. Rodríguez EE, Odriozola EE. New criteria for personality disorders in DSM-V. Actas Esp Psiquiatr. 2011;39:1–11.
    1. Malin K, Littlejohn GO. Personality and fibromyalgia syndrome. Open Rheumatol J. 2012;6:273–85. doi: 10.2174/1874312901206010273.
    1. Echeburúa E, Fernández-Montalvo J. Use and abuse of self-reports in the assessment of personality disorders. Rev Psicopatol Psicol Clin. 2006;11:1–12.
    1. Skodol AE, Pagano ME, Bender DS, Shea MT, Gunderson JG, Yen S, et al. Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder. Am J Psychiatry. 2002;159:276–83.
    1. Chen H, Cohen P, Kasen S, Johnson JG, Berenson K, Gordon K. Impact of adolescent mental disorders and physical illnesses on quality of life 17 years later. Arch Pediatr Adolesc Med. 2006;160:93–9. doi: 10.1001/archpedi.160.1.93.
    1. Walen HR, Cronan PA, Bigatti SM. Factors associated with healthcare costs in women with fibromyalgia. Am J Manag Care. 2001;7:39–47.
    1. Penrod JR, Bernatsky S, Adam V, Baron M, Dayan N, Dobkin PL. Health services costs and their determinants in women with fibromyalgia. J Rheumatol. 2004;31:1391–8.
    1. Jackson HJ, Burgess PM. Personality disorders in the community: a report from the Australian national survey of mental health and wellbeing. Soc Psychiatry Psychiatr Epidemiol. 2000;35:531–8. doi: 10.1007/s001270050276.
    1. Olssøn I, Dahl AA. Personality problems are considerably associated with somatic morbidity and health care utilisation. Eur Psychiatry. 2009;24:442–9. doi: 10.1016/j.eurpsy.2009.05.004.
    1. Cuesta-Vargas A, Luciano JV, Peñarrubia-María MT, García-Campayo J, Fernández-Vergel R, Arroyo-Morales M, et al. Clinical dimensions of fibromyalgia symptoms and development of a combined index of severity: the CODI index. Qual Life Res. 2013;22:153–60.
    1. Ullrich S, Deasy D, Smith J, Johnson B, Clarke M, Broughton N, et al. Detecting personality disorders in the prison population of England and Wales: comparing case identification using the SCID-II screen and the SCID-II clinical interview. J Forens Psychiatry Psychol. 2008;19:301–22.
    1. Reich J. The effect of axis II disorders on the outcome of treatment of anxiety and unipolar depressive disorders: a review. J Personal Disord. 2003;17:387–405. doi: 10.1521/pedi.17.5.387.22972.
    1. Grilo CM, Sanislow CA, Shea MT, Skodol AE, Stout RL, Gunderson JG, et al. Two-year prospective naturalistic study of remission from major depressive disorder as a function of personality disorder comorbidity. J Consult Clin Psychol. 2005;73:78–85.
    1. Ten Kate CA, Eurelings-Bontekoe EHM, Muller N, Spinhoven P. Personality disorders in an institution for ambulatory mental health care. Prevalence, type and severity, treatment indication and drop out. Tijdschr Voor Psychiatr. 2007;49:597–609.
    1. Luciano JV, García-Forero C, Cerdà-Lafont M, Peñarrubia-María MT, Fernández-Vergel R, Cuesta-Vargas AI, et al. Functional status, quality of life, and costs associated with fibromyalgia subgroups: a latent profile analysis. Clin J Pain. 2015. In press.
    1. Arnold LM, Gebke KB, Choy EH. Fibromyalgia: management strategies for primary care providers. Int J Clin Pract. 2016;70:99–112. doi: 10.1111/ijcp.12757.
    1. Kianmehr N, Haghighi A, Bidari A, Sharafian Ardekani Y, Karimi MA. Are general practitioners well informed about fibromyalgia? Int J Rheum Dis. 2015.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться